Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Birth Outcomes in Eswatini After Transition to Dolutegravir-based Treatment

NCT05883761 is registered in ClinicalTrials.gov with Elizabeth Glaser Pediatric AIDS Foundation as lead sponsor.

NCT NCT05883761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05883761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Birth Outcomes in Eswatini After Transition to Dolutegravir-based Treatment
Lead sponsor
Elizabeth Glaser Pediatric AIDS Foundation
Phase
Observational
Overall status
Completed
Start date
September 7, 2021
Completion date
September 30, 2023
Enrollment
50,075 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

congenital abnormalities, neural tube defects, teratogens